These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36322257)

  • 1. Phthalates cause a low-renin phenotype commonly found in premature infants with idiopathic neonatal hypertension.
    Jenkins RD
    Pediatr Nephrol; 2023 Jun; 38(6):1717-1724. PubMed ID: 36322257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phthalate-associated hypertension in premature infants: a prospective mechanistic cohort study.
    Jenkins R; Tackitt S; Gievers L; Iragorri S; Sage K; Cornwall T; O'Riordan D; Merchant J; Rozansky D
    Pediatr Nephrol; 2019 Aug; 34(8):1413-1424. PubMed ID: 31028470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-dependent inhibition of human and rat 11beta-hydroxysteroid dehydrogenase 2 activities by phthalates.
    Zhao B; Chu Y; Huang Y; Hardy DO; Lin S; Ge RS
    Chem Biol Interact; 2010 Jan; 183(1):79-84. PubMed ID: 19786001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal overexposure to glucocorticoids programs renal 11β-hydroxysteroid dehydrogenase type 2 expression and salt-sensitive hypertension in the rat.
    Tang JI; Kenyon CJ; Seckl JR; Nyirenda MJ
    J Hypertens; 2011 Feb; 29(2):282-9. PubMed ID: 21045727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess.
    Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A
    J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C; Martinez-Aguayo A; Baudrand R; Carvajal CA; Aglony M; Garcia H; Padilla O; Kalergis AM; Fardella CE
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery.
    Dy J; Guan H; Sampath-Kumar R; Richardson BS; Yang K
    Placenta; 2008 Feb; 29(2):193-200. PubMed ID: 18061258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent Mineralocorticoid Excess in the Pediatric Population: Report of a Novel Pathogenic Variant of the 11β-HSD2 Gene and Systematic Review of the Literature.
    Adamidis A; Cantas-Orsdemir S; Tsirka A; Abbott MA; Visintainer P; Tonyushkina K
    Pediatr Endocrinol Rev; 2019 Mar; 16(3):335-358. PubMed ID: 30888125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mono-(2-ethylhexyl) phthalate (MEHP) regulates glucocorticoid metabolism through 11beta-hydroxysteroid dehydrogenase 2 in murine gonadotrope cells.
    Hong D; Li XW; Lian QQ; Lamba P; Bernard DJ; Hardy DO; Chen HX; Ge RS
    Biochem Biophys Res Commun; 2009 Nov; 389(2):305-9. PubMed ID: 19720048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent mineralocorticoid excess in a Brazilian kindred: hypertension in the heterozygote state.
    Li A; Li KX; Marui S; Krozowski ZS; Batista MC; Whorwood CB; Arnhold IJ; Shackleton CH; Mendonca BB; Stewart PM
    J Hypertens; 1997 Dec; 15(12 Pt 1):1397-402. PubMed ID: 9431844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11β-Hydroxysteroid dehydrogenase type-2 and type-1 (11β-HSD2 and 11β-HSD1) and 5β-reductase activities in the pathogenia of essential hypertension.
    Campino C; Carvajal CA; Cornejo J; San Martín B; Olivieri O; Guidi G; Faccini G; Pasini F; Sateler J; Baudrand R; Mosso L; Owen GI; Kalergis AM; Padilla O; Fardella CE
    Endocrine; 2010 Feb; 37(1):106-14. PubMed ID: 19882252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension.
    Ferrari P; Lovati E; Frey FJ
    J Hypertens; 2000 Mar; 18(3):241-8. PubMed ID: 10726708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placental 11beta-HSD2 activity, early postnatal clinical course, and adrenal function in extremely low birth weight infants.
    Kajantie E; Dunkel L; Turpeinen U; Stenman UH; Andersson S
    Pediatr Res; 2006 Apr; 59(4 Pt 1):575-8. PubMed ID: 16549532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Glorioso N; Filigheddu F; Parpaglia PP; Soro A; Troffa C; Argiolas G; Mulatero P
    Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of Intravenous Di-2-Ethylhexyl Phthalate Exposure Abrogates Most Neonatal Hypertension in Premature Infants with Bronchopulmonary Dysplasia.
    Jenkins R; Farnbach K; Iragorri S
    Toxics; 2021 Apr; 9(4):. PubMed ID: 33918157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Biochemical, and Genetic Characteristics of "Nonclassic" Apparent Mineralocorticoid Excess Syndrome.
    Tapia-Castillo A; Baudrand R; Vaidya A; Campino C; Allende F; Valdivia C; Vecchiola A; Lagos CF; Fuentes CA; Solari S; Martínez-Aguayo A; García H; Carvajal CA; Fardella CE
    J Clin Endocrinol Metab; 2019 Feb; 104(2):595-603. PubMed ID: 30239803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids].
    Levtchenko EN; Deinum J; Knoers NV; Hermus AR; Monnens LA; Lenders JW
    Ned Tijdschr Geneeskd; 2007 Mar; 151(12):692-4. PubMed ID: 17447595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone effective hypertension in the elderly due to 11beta-hydroxysteroid dehydrogenase type 2 (11beta-HSD2) impairment: contributory role of determining serum cortisol/cortisone ratio as a marker of 11beta-HSD2 activity.
    Inada M; Iwasaki K; Imai C; Hashimoto S
    Intern Med; 2008; 47(24):2157-64. PubMed ID: 19075542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L; Carvajal C; Campino C; Rojas A; González A; Barraza A; Montero J; Fardella C
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.